Legal & General Group PLC Pulse Biosciences, Inc. Transaction History
Legal & General Group PLC
- $368 Billion
- Q4 2024
A detailed history of Legal & General Group PLC transactions in Pulse Biosciences, Inc. stock. As of the latest transaction made, Legal & General Group PLC holds 18,303 shares of PLSE stock, worth $310,235. This represents 0.0% of its overall portfolio holdings.
Number of Shares
18,303
Previous 14,782
23.82%
Holding current value
$310,235
Previous $259,000
30.5%
% of portfolio
0.0%
Previous 0.0%
Shares
17 transactions
Others Institutions Holding PLSE
# of Institutions
78Shares Held
5.75MCall Options Held
94.9KPut Options Held
52K-
Black Rock Inc. New York, NY1.15MShares$19.4 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.15MShares$19.4 Million0.0% of portfolio
-
Bank Of America Corp Charlotte, NC788KShares$13.4 Million0.0% of portfolio
-
State Street Corp Boston, MA474KShares$8.04 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA461KShares$7.81 Million0.0% of portfolio
About Pulse Biosciences, Inc.
- Ticker PLSE
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 37,125,900
- Market Cap $629M
- Description
- Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. It offers CellFX System, a tunable, software-enabled, and console-based platform that delivers nano second duration pulses of electrical energy to non-thermally clear targeted cells while sparing adjacent non-cellular tissue to treat a various medical condition by using it...